Global Vaccine for Non-infectious Meningitis Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Vaccine for Non-infectious Meningitis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Vaccine for Non-infectious Meningitis market size is estimated to be worth US$ 1 million in 2021 and is forecast to a readjusted size of USD 2 million by 2028 with a CAGR of 11.5% during review period. Meningitis accounting for % of the Vaccine for Non-infectious Meningitis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Polysaccharide Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Vaccine for Non-infectious Meningitis include Serum Institute, Sanofi SA, Pfizer, Nuron Biotech, and JN-International Medical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Vaccine for Non-infectious Meningitis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Vaccine for Non-infectious Meningitis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccine for Non-infectious Meningitis, with price, sales, revenue and global market share of Vaccine for Non-infectious Meningitis from 2019 to 2022.
Chapter 3, the Vaccine for Non-infectious Meningitis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine for Non-infectious Meningitis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Vaccine for Non-infectious Meningitis market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vaccine for Non-infectious Meningitis.
Chapter 13, 14, and 15, to describe Vaccine for Non-infectious Meningitis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Vaccine for Non-infectious Meningitis market size is estimated to be worth US$ 1 million in 2021 and is forecast to a readjusted size of USD 2 million by 2028 with a CAGR of 11.5% during review period. Meningitis accounting for % of the Vaccine for Non-infectious Meningitis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Polysaccharide Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Vaccine for Non-infectious Meningitis include Serum Institute, Sanofi SA, Pfizer, Nuron Biotech, and JN-International Medical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Vaccine for Non-infectious Meningitis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Polysaccharide Vaccines
- Conjugate Vaccines
- Combination Vaccines
- Men B Vaccines
- Meningitis
- Septicemia
- Others
- Serum Institute
- Sanofi SA
- Pfizer
- Nuron Biotech
- JN-International Medical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Vaccine for Non-infectious Meningitis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccine for Non-infectious Meningitis, with price, sales, revenue and global market share of Vaccine for Non-infectious Meningitis from 2019 to 2022.
Chapter 3, the Vaccine for Non-infectious Meningitis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine for Non-infectious Meningitis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Vaccine for Non-infectious Meningitis market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vaccine for Non-infectious Meningitis.
Chapter 13, 14, and 15, to describe Vaccine for Non-infectious Meningitis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Vaccine for Non-infectious Meningitis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaccine for Non-infectious Meningitis Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Polysaccharide Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Combination Vaccines
1.2.5 Men B Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaccine for Non-infectious Meningitis Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Meningitis
1.3.3 Septicemia
1.3.4 Others
1.4 Global Vaccine for Non-infectious Meningitis Market Size & Forecast
1.4.1 Global Vaccine for Non-infectious Meningitis Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Vaccine for Non-infectious Meningitis Sales in Volume (2017-2028)
1.4.3 Global Vaccine for Non-infectious Meningitis Price (2017-2028)
1.5 Global Vaccine for Non-infectious Meningitis Production Capacity Analysis
1.5.1 Global Vaccine for Non-infectious Meningitis Total Production Capacity (2017-2028)
1.5.2 Global Vaccine for Non-infectious Meningitis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaccine for Non-infectious Meningitis Market Drivers
1.6.2 Vaccine for Non-infectious Meningitis Market Restraints
1.6.3 Vaccine for Non-infectious Meningitis Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Serum Institute
2.1.1 Serum Institute Details
2.1.2 Serum Institute Major Business
2.1.3 Serum Institute Vaccine for Non-infectious Meningitis Product and Services
2.1.4 Serum Institute Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi SA
2.2.1 Sanofi SA Details
2.2.2 Sanofi SA Major Business
2.2.3 Sanofi SA Vaccine for Non-infectious Meningitis Product and Services
2.2.4 Sanofi SA Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Vaccine for Non-infectious Meningitis Product and Services
2.3.4 Pfizer Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Nuron Biotech
2.4.1 Nuron Biotech Details
2.4.2 Nuron Biotech Major Business
2.4.3 Nuron Biotech Vaccine for Non-infectious Meningitis Product and Services
2.4.4 Nuron Biotech Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 JN-International Medical
2.5.1 JN-International Medical Details
2.5.2 JN-International Medical Major Business
2.5.3 JN-International Medical Vaccine for Non-infectious Meningitis Product and Services
2.5.4 JN-International Medical Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 VACCINE FOR NON-INFECTIOUS MENINGITIS BREAKDOWN DATA BY MANUFACTURER
3.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Vaccine for Non-infectious Meningitis Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Vaccine for Non-infectious Meningitis
3.4 Market Concentration Rate
3.4.1 Top 3 Vaccine for Non-infectious Meningitis Manufacturer Market Share in 2021
3.4.2 Top 6 Vaccine for Non-infectious Meningitis Manufacturer Market Share in 2021
3.5 Global Vaccine for Non-infectious Meningitis Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Vaccine for Non-infectious Meningitis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Vaccine for Non-infectious Meningitis Market Size by Region
4.1.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Region (2017-2028)
4.1.2 Global Vaccine for Non-infectious Meningitis Revenue by Region (2017-2028)
4.2 North America Vaccine for Non-infectious Meningitis Revenue (2017-2028)
4.3 Europe Vaccine for Non-infectious Meningitis Revenue (2017-2028)
4.4 Asia-Pacific Vaccine for Non-infectious Meningitis Revenue (2017-2028)
4.5 South America Vaccine for Non-infectious Meningitis Revenue (2017-2028)
4.6 Middle East and Africa Vaccine for Non-infectious Meningitis Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Type (2017-2028)
5.2 Global Vaccine for Non-infectious Meningitis Revenue by Type (2017-2028)
5.3 Global Vaccine for Non-infectious Meningitis Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Application (2017-2028)
6.2 Global Vaccine for Non-infectious Meningitis Revenue by Application (2017-2028)
6.3 Global Vaccine for Non-infectious Meningitis Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Vaccine for Non-infectious Meningitis Sales by Type (2017-2028)
7.2 North America Vaccine for Non-infectious Meningitis Sales by Application (2017-2028)
7.3 North America Vaccine for Non-infectious Meningitis Market Size by Country
7.3.1 North America Vaccine for Non-infectious Meningitis Sales in Volume by Country (2017-2028)
7.3.2 North America Vaccine for Non-infectious Meningitis Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Vaccine for Non-infectious Meningitis Sales by Type (2017-2028)
8.2 Europe Vaccine for Non-infectious Meningitis Sales by Application (2017-2028)
8.3 Europe Vaccine for Non-infectious Meningitis Market Size by Country
8.3.1 Europe Vaccine for Non-infectious Meningitis Sales in Volume by Country (2017-2028)
8.3.2 Europe Vaccine for Non-infectious Meningitis Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Type (2017-2028)
9.2 Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Application (2017-2028)
9.3 Asia-Pacific Vaccine for Non-infectious Meningitis Market Size by Region
9.3.1 Asia-Pacific Vaccine for Non-infectious Meningitis Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Vaccine for Non-infectious Meningitis Sales by Type (2017-2028)
10.2 South America Vaccine for Non-infectious Meningitis Sales by Application (2017-2028)
10.3 South America Vaccine for Non-infectious Meningitis Market Size by Country
10.3.1 South America Vaccine for Non-infectious Meningitis Sales in Volume by Country (2017-2028)
10.3.2 South America Vaccine for Non-infectious Meningitis Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2017-2028)
11.2 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2017-2028)
11.3 Middle East & Africa Vaccine for Non-infectious Meningitis Market Size by Country
11.3.1 Middle East & Africa Vaccine for Non-infectious Meningitis Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Vaccine for Non-infectious Meningitis and Key Manufacturers
12.2 Manufacturing Costs Percentage of Vaccine for Non-infectious Meningitis
12.3 Vaccine for Non-infectious Meningitis Production Process
12.4 Vaccine for Non-infectious Meningitis Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Vaccine for Non-infectious Meningitis Typical Distributors
13.3 Vaccine for Non-infectious Meningitis Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 Vaccine for Non-infectious Meningitis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaccine for Non-infectious Meningitis Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Polysaccharide Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Combination Vaccines
1.2.5 Men B Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaccine for Non-infectious Meningitis Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Meningitis
1.3.3 Septicemia
1.3.4 Others
1.4 Global Vaccine for Non-infectious Meningitis Market Size & Forecast
1.4.1 Global Vaccine for Non-infectious Meningitis Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Vaccine for Non-infectious Meningitis Sales in Volume (2017-2028)
1.4.3 Global Vaccine for Non-infectious Meningitis Price (2017-2028)
1.5 Global Vaccine for Non-infectious Meningitis Production Capacity Analysis
1.5.1 Global Vaccine for Non-infectious Meningitis Total Production Capacity (2017-2028)
1.5.2 Global Vaccine for Non-infectious Meningitis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaccine for Non-infectious Meningitis Market Drivers
1.6.2 Vaccine for Non-infectious Meningitis Market Restraints
1.6.3 Vaccine for Non-infectious Meningitis Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Serum Institute
2.1.1 Serum Institute Details
2.1.2 Serum Institute Major Business
2.1.3 Serum Institute Vaccine for Non-infectious Meningitis Product and Services
2.1.4 Serum Institute Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi SA
2.2.1 Sanofi SA Details
2.2.2 Sanofi SA Major Business
2.2.3 Sanofi SA Vaccine for Non-infectious Meningitis Product and Services
2.2.4 Sanofi SA Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Vaccine for Non-infectious Meningitis Product and Services
2.3.4 Pfizer Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Nuron Biotech
2.4.1 Nuron Biotech Details
2.4.2 Nuron Biotech Major Business
2.4.3 Nuron Biotech Vaccine for Non-infectious Meningitis Product and Services
2.4.4 Nuron Biotech Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 JN-International Medical
2.5.1 JN-International Medical Details
2.5.2 JN-International Medical Major Business
2.5.3 JN-International Medical Vaccine for Non-infectious Meningitis Product and Services
2.5.4 JN-International Medical Vaccine for Non-infectious Meningitis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 VACCINE FOR NON-INFECTIOUS MENINGITIS BREAKDOWN DATA BY MANUFACTURER
3.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Vaccine for Non-infectious Meningitis Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Vaccine for Non-infectious Meningitis
3.4 Market Concentration Rate
3.4.1 Top 3 Vaccine for Non-infectious Meningitis Manufacturer Market Share in 2021
3.4.2 Top 6 Vaccine for Non-infectious Meningitis Manufacturer Market Share in 2021
3.5 Global Vaccine for Non-infectious Meningitis Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Vaccine for Non-infectious Meningitis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Vaccine for Non-infectious Meningitis Market Size by Region
4.1.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Region (2017-2028)
4.1.2 Global Vaccine for Non-infectious Meningitis Revenue by Region (2017-2028)
4.2 North America Vaccine for Non-infectious Meningitis Revenue (2017-2028)
4.3 Europe Vaccine for Non-infectious Meningitis Revenue (2017-2028)
4.4 Asia-Pacific Vaccine for Non-infectious Meningitis Revenue (2017-2028)
4.5 South America Vaccine for Non-infectious Meningitis Revenue (2017-2028)
4.6 Middle East and Africa Vaccine for Non-infectious Meningitis Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Type (2017-2028)
5.2 Global Vaccine for Non-infectious Meningitis Revenue by Type (2017-2028)
5.3 Global Vaccine for Non-infectious Meningitis Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Vaccine for Non-infectious Meningitis Sales in Volume by Application (2017-2028)
6.2 Global Vaccine for Non-infectious Meningitis Revenue by Application (2017-2028)
6.3 Global Vaccine for Non-infectious Meningitis Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Vaccine for Non-infectious Meningitis Sales by Type (2017-2028)
7.2 North America Vaccine for Non-infectious Meningitis Sales by Application (2017-2028)
7.3 North America Vaccine for Non-infectious Meningitis Market Size by Country
7.3.1 North America Vaccine for Non-infectious Meningitis Sales in Volume by Country (2017-2028)
7.3.2 North America Vaccine for Non-infectious Meningitis Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Vaccine for Non-infectious Meningitis Sales by Type (2017-2028)
8.2 Europe Vaccine for Non-infectious Meningitis Sales by Application (2017-2028)
8.3 Europe Vaccine for Non-infectious Meningitis Market Size by Country
8.3.1 Europe Vaccine for Non-infectious Meningitis Sales in Volume by Country (2017-2028)
8.3.2 Europe Vaccine for Non-infectious Meningitis Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Type (2017-2028)
9.2 Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Application (2017-2028)
9.3 Asia-Pacific Vaccine for Non-infectious Meningitis Market Size by Region
9.3.1 Asia-Pacific Vaccine for Non-infectious Meningitis Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Vaccine for Non-infectious Meningitis Sales by Type (2017-2028)
10.2 South America Vaccine for Non-infectious Meningitis Sales by Application (2017-2028)
10.3 South America Vaccine for Non-infectious Meningitis Market Size by Country
10.3.1 South America Vaccine for Non-infectious Meningitis Sales in Volume by Country (2017-2028)
10.3.2 South America Vaccine for Non-infectious Meningitis Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2017-2028)
11.2 Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2017-2028)
11.3 Middle East & Africa Vaccine for Non-infectious Meningitis Market Size by Country
11.3.1 Middle East & Africa Vaccine for Non-infectious Meningitis Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Vaccine for Non-infectious Meningitis and Key Manufacturers
12.2 Manufacturing Costs Percentage of Vaccine for Non-infectious Meningitis
12.3 Vaccine for Non-infectious Meningitis Production Process
12.4 Vaccine for Non-infectious Meningitis Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Vaccine for Non-infectious Meningitis Typical Distributors
13.3 Vaccine for Non-infectious Meningitis Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Vaccine for Non-infectious Meningitis Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Vaccine for Non-infectious Meningitis Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 4. Serum Institute Major Business
Table 5. Serum Institute Vaccine for Non-infectious Meningitis Product and Services
Table 6. Serum Institute Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi SA Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi SA Major Business
Table 9. Sanofi SA Vaccine for Non-infectious Meningitis Product and Services
Table 10. Sanofi SA Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Vaccine for Non-infectious Meningitis Product and Services
Table 14. Pfizer Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Nuron Biotech Basic Information, Manufacturing Base and Competitors
Table 16. Nuron Biotech Major Business
Table 17. Nuron Biotech Vaccine for Non-infectious Meningitis Product and Services
Table 18. Nuron Biotech Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. JN-International Medical Basic Information, Manufacturing Base and Competitors
Table 20. JN-International Medical Major Business
Table 21. JN-International Medical Vaccine for Non-infectious Meningitis Product and Services
Table 22. JN-International Medical Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Vaccine for Non-infectious Meningitis Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Vaccine for Non-infectious Meningitis Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Vaccine for Non-infectious Meningitis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Vaccine for Non-infectious Meningitis Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Vaccine for Non-infectious Meningitis Production Site of Key Manufacturer
Table 28. Vaccine for Non-infectious Meningitis New Entrant and Capacity Expansion Plans
Table 29. Vaccine for Non-infectious Meningitis Mergers & Acquisitions in the Past Five Years
Table 30. Global Vaccine for Non-infectious Meningitis Sales by Region (2017-2022) & (K Units)
Table 31. Global Vaccine for Non-infectious Meningitis Sales by Region (2023-2028) & (K Units)
Table 32. Global Vaccine for Non-infectious Meningitis Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Vaccine for Non-infectious Meningitis Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 35. Global Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 36. Global Vaccine for Non-infectious Meningitis Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Vaccine for Non-infectious Meningitis Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Vaccine for Non-infectious Meningitis Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Vaccine for Non-infectious Meningitis Price by Type (2023-2028) & (USD/Unit)
Table 40. Global Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 41. Global Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 42. Global Vaccine for Non-infectious Meningitis Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Vaccine for Non-infectious Meningitis Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Vaccine for Non-infectious Meningitis Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Vaccine for Non-infectious Meningitis Price by Application (2023-2028) & (USD/Unit)
Table 46. North America Vaccine for Non-infectious Meningitis Sales by Country (2017-2022) & (K Units)
Table 47. North America Vaccine for Non-infectious Meningitis Sales by Country (2023-2028) & (K Units)
Table 48. North America Vaccine for Non-infectious Meningitis Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Vaccine for Non-infectious Meningitis Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 51. North America Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 52. North America Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 53. North America Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 54. Europe Vaccine for Non-infectious Meningitis Sales by Country (2017-2022) & (K Units)
Table 55. Europe Vaccine for Non-infectious Meningitis Sales by Country (2023-2028) & (K Units)
Table 56. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 59. Europe Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 60. Europe Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 61. Europe Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 70. South America Vaccine for Non-infectious Meningitis Sales by Country (2017-2022) & (K Units)
Table 71. South America Vaccine for Non-infectious Meningitis Sales by Country (2023-2028) & (K Units)
Table 72. South America Vaccine for Non-infectious Meningitis Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Vaccine for Non-infectious Meningitis Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 75. South America Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 76. South America Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 77. South America Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 86. Vaccine for Non-infectious Meningitis Raw Material
Table 87. Key Manufacturers of Vaccine for Non-infectious Meningitis Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Vaccine for Non-infectious Meningitis Typical Distributors
Table 91. Vaccine for Non-infectious Meningitis Typical Customers
Table 1. Global Vaccine for Non-infectious Meningitis Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Vaccine for Non-infectious Meningitis Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 4. Serum Institute Major Business
Table 5. Serum Institute Vaccine for Non-infectious Meningitis Product and Services
Table 6. Serum Institute Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi SA Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi SA Major Business
Table 9. Sanofi SA Vaccine for Non-infectious Meningitis Product and Services
Table 10. Sanofi SA Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Vaccine for Non-infectious Meningitis Product and Services
Table 14. Pfizer Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Nuron Biotech Basic Information, Manufacturing Base and Competitors
Table 16. Nuron Biotech Major Business
Table 17. Nuron Biotech Vaccine for Non-infectious Meningitis Product and Services
Table 18. Nuron Biotech Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. JN-International Medical Basic Information, Manufacturing Base and Competitors
Table 20. JN-International Medical Major Business
Table 21. JN-International Medical Vaccine for Non-infectious Meningitis Product and Services
Table 22. JN-International Medical Vaccine for Non-infectious Meningitis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Vaccine for Non-infectious Meningitis Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Vaccine for Non-infectious Meningitis Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Vaccine for Non-infectious Meningitis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Vaccine for Non-infectious Meningitis Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Vaccine for Non-infectious Meningitis Production Site of Key Manufacturer
Table 28. Vaccine for Non-infectious Meningitis New Entrant and Capacity Expansion Plans
Table 29. Vaccine for Non-infectious Meningitis Mergers & Acquisitions in the Past Five Years
Table 30. Global Vaccine for Non-infectious Meningitis Sales by Region (2017-2022) & (K Units)
Table 31. Global Vaccine for Non-infectious Meningitis Sales by Region (2023-2028) & (K Units)
Table 32. Global Vaccine for Non-infectious Meningitis Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Vaccine for Non-infectious Meningitis Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 35. Global Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 36. Global Vaccine for Non-infectious Meningitis Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Vaccine for Non-infectious Meningitis Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Vaccine for Non-infectious Meningitis Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Vaccine for Non-infectious Meningitis Price by Type (2023-2028) & (USD/Unit)
Table 40. Global Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 41. Global Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 42. Global Vaccine for Non-infectious Meningitis Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Vaccine for Non-infectious Meningitis Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Vaccine for Non-infectious Meningitis Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Vaccine for Non-infectious Meningitis Price by Application (2023-2028) & (USD/Unit)
Table 46. North America Vaccine for Non-infectious Meningitis Sales by Country (2017-2022) & (K Units)
Table 47. North America Vaccine for Non-infectious Meningitis Sales by Country (2023-2028) & (K Units)
Table 48. North America Vaccine for Non-infectious Meningitis Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Vaccine for Non-infectious Meningitis Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 51. North America Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 52. North America Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 53. North America Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 54. Europe Vaccine for Non-infectious Meningitis Sales by Country (2017-2022) & (K Units)
Table 55. Europe Vaccine for Non-infectious Meningitis Sales by Country (2023-2028) & (K Units)
Table 56. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 59. Europe Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 60. Europe Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 61. Europe Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 70. South America Vaccine for Non-infectious Meningitis Sales by Country (2017-2022) & (K Units)
Table 71. South America Vaccine for Non-infectious Meningitis Sales by Country (2023-2028) & (K Units)
Table 72. South America Vaccine for Non-infectious Meningitis Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Vaccine for Non-infectious Meningitis Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 75. South America Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 76. South America Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 77. South America Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Vaccine for Non-infectious Meningitis Sales by Application (2023-2028) & (K Units)
Table 86. Vaccine for Non-infectious Meningitis Raw Material
Table 87. Key Manufacturers of Vaccine for Non-infectious Meningitis Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Vaccine for Non-infectious Meningitis Typical Distributors
Table 91. Vaccine for Non-infectious Meningitis Typical Customers
LIST OF FIGURES
Figure 1. Vaccine for Non-infectious Meningitis Picture
Figure 2. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type in 2021
Figure 3. Polysaccharide Vaccines
Figure 4. Conjugate Vaccines
Figure 5. Combination Vaccines
Figure 6. Men B Vaccines
Figure 7. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application in 2021
Figure 8. Meningitis
Figure 9. Septicemia
Figure 10. Others
Figure 11. Global Vaccine for Non-infectious Meningitis Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Vaccine for Non-infectious Meningitis Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Vaccine for Non-infectious Meningitis Sales (2017-2028) & (K Units)
Figure 14. Global Vaccine for Non-infectious Meningitis Price (2017-2028) & (USD/Unit)
Figure 15. Global Vaccine for Non-infectious Meningitis Production Capacity (2017-2028) & (K Units)
Figure 16. Global Vaccine for Non-infectious Meningitis Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Vaccine for Non-infectious Meningitis Market Drivers
Figure 18. Vaccine for Non-infectious Meningitis Market Restraints
Figure 19. Vaccine for Non-infectious Meningitis Market Trends
Figure 20. Global Vaccine for Non-infectious Meningitis Sales Market Share by Manufacturer in 2021
Figure 21. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Manufacturer in 2021
Figure 22. Vaccine for Non-infectious Meningitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Vaccine for Non-infectious Meningitis Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Vaccine for Non-infectious Meningitis Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Vaccine for Non-infectious Meningitis Sales Market Share by Region (2017-2028)
Figure 26. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2017-2028)
Figure 27. North America Vaccine for Non-infectious Meningitis Revenue (2017-2028) & (USD Million)
Figure 28. Europe Vaccine for Non-infectious Meningitis Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue (2017-2028) & (USD Million)
Figure 30. South America Vaccine for Non-infectious Meningitis Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue (2017-2028) & (USD Million)
Figure 32. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2017-2028)
Figure 33. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2017-2028)
Figure 34. Global Vaccine for Non-infectious Meningitis Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 36. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2017-2028)
Figure 37. Global Vaccine for Non-infectious Meningitis Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Vaccine for Non-infectious Meningitis Sales Market Share by Type (2017-2028)
Figure 39. North America Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 40. North America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2017-2028)
Figure 41. North America Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2017-2028)
Figure 42. United States Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Type (2017-2028)
Figure 46. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 47. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Country (2017-2028)
Figure 48. Europe Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2017-2028)
Figure 49. Germany Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2017-2028)
Figure 58. China Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Vaccine for Non-infectious Meningitis Sales Market Share by Type (2017-2028)
Figure 65. South America Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 66. South America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2017-2028)
Figure 67. South America Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Vaccine for Non-infectious Meningitis in 2021
Figure 79. Manufacturing Process Analysis of Vaccine for Non-infectious Meningitis
Figure 80. Vaccine for Non-infectious Meningitis Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Vaccine for Non-infectious Meningitis Picture
Figure 2. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type in 2021
Figure 3. Polysaccharide Vaccines
Figure 4. Conjugate Vaccines
Figure 5. Combination Vaccines
Figure 6. Men B Vaccines
Figure 7. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application in 2021
Figure 8. Meningitis
Figure 9. Septicemia
Figure 10. Others
Figure 11. Global Vaccine for Non-infectious Meningitis Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Vaccine for Non-infectious Meningitis Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Vaccine for Non-infectious Meningitis Sales (2017-2028) & (K Units)
Figure 14. Global Vaccine for Non-infectious Meningitis Price (2017-2028) & (USD/Unit)
Figure 15. Global Vaccine for Non-infectious Meningitis Production Capacity (2017-2028) & (K Units)
Figure 16. Global Vaccine for Non-infectious Meningitis Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Vaccine for Non-infectious Meningitis Market Drivers
Figure 18. Vaccine for Non-infectious Meningitis Market Restraints
Figure 19. Vaccine for Non-infectious Meningitis Market Trends
Figure 20. Global Vaccine for Non-infectious Meningitis Sales Market Share by Manufacturer in 2021
Figure 21. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Manufacturer in 2021
Figure 22. Vaccine for Non-infectious Meningitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Vaccine for Non-infectious Meningitis Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Vaccine for Non-infectious Meningitis Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Vaccine for Non-infectious Meningitis Sales Market Share by Region (2017-2028)
Figure 26. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2017-2028)
Figure 27. North America Vaccine for Non-infectious Meningitis Revenue (2017-2028) & (USD Million)
Figure 28. Europe Vaccine for Non-infectious Meningitis Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue (2017-2028) & (USD Million)
Figure 30. South America Vaccine for Non-infectious Meningitis Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue (2017-2028) & (USD Million)
Figure 32. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2017-2028)
Figure 33. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2017-2028)
Figure 34. Global Vaccine for Non-infectious Meningitis Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 36. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2017-2028)
Figure 37. Global Vaccine for Non-infectious Meningitis Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Vaccine for Non-infectious Meningitis Sales Market Share by Type (2017-2028)
Figure 39. North America Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 40. North America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2017-2028)
Figure 41. North America Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2017-2028)
Figure 42. United States Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Type (2017-2028)
Figure 46. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 47. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Country (2017-2028)
Figure 48. Europe Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2017-2028)
Figure 49. Germany Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2017-2028)
Figure 58. China Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Vaccine for Non-infectious Meningitis Sales Market Share by Type (2017-2028)
Figure 65. South America Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 66. South America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2017-2028)
Figure 67. South America Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Vaccine for Non-infectious Meningitis Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Vaccine for Non-infectious Meningitis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Vaccine for Non-infectious Meningitis in 2021
Figure 79. Manufacturing Process Analysis of Vaccine for Non-infectious Meningitis
Figure 80. Vaccine for Non-infectious Meningitis Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
